In this webinar, we describe what content standards are and why they are important. We introduce the Five Dimensions of Content Standardization™. We show how our content standardization framework makes content FAIR (findable, accessible, interoperable, and reusable). Finally, we suggest some next steps that you can take to prepare your
To help create safe, effective medicines in less time, you must change how you “do” content. You need to harness the power of content reuse and automation. You also need to prepare for digital submissions and AI-based content generation. To do that, you need to move toward a component-based, structured
Most content challenges are ubiquitous, present in every vertical. Processes that don’t scale. Too much content to manage and yet the exact right content never seems to be at hand. Authors must copy and paste and (inevitably) tweak content, wasting time and increasing risk. The challenges of time, cost, and
Earlier this year, I took a course on artificial intelligence taught at the Executive Education division of the UC Berkeley Haas School of Management. The course was primarily focused on AI business strategies and applications.
Efforts without tools do not work. Efforts are just that. Best intentions. And while we all have the best intentions, we also have full-time jobs. This is why we have tools. To make things efficient and consistent.
I recently finished a great course on artificial intelligence offered by the UC Berkeley Haas School of Management. It was an eight week course that was mostly directed at the business of AI, rather than coding or technology. Really good stuff.
Search and findability issues are the number one complaint that I hear from customers who realize they need a content strategy. Well over 50% of customers from our content strategy practice start conversations by telling me that their search is “broken.”
I recently came across a great commentary in the August 2021 issue of “Pharma Technology Focus.” The article is titled, “MDR set to transform how MedTech firms approach content management,” written by Barbara Peraltor, Director of Life Science Solutions at Amplexor.
EU Medical Device Regulation (2017/745) and In Vitro Diagnostic Regulation (2017/746) went into effect in May 2021, after about a year’s delay due to COVID-19. Medical device manufacturers have known about the new regulations for years and have been working to meet these new, more stringent standards.
I’ve started to notice a trend in structured authoring. In the past, almost all of our customers who implemented structured authoring were established companies with a lot of legacy content. And most of the writers were very technical. Rarely did I see young companies implement structured authoring from the beginning.